ArticleThoracic cancer2016

MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutation.

Yuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.